These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 25456839)
1. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer. Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients. Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification. Sakura Y; Yamashita R; Notsu A; Usui K; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M Int J Urol; 2024 Jul; 31(7):785-792. PubMed ID: 38606834 [TBL] [Abstract][Full Text] [Related]
5. Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. Zargar-Shoshtari K; Kongnyuy M; Sharma P; Fishman MN; Gilbert SM; Poch MA; Pow-Sang JM; Spiess PE; Zhang J; Sexton WJ World J Urol; 2016 Nov; 34(11):1567-1573. PubMed ID: 27072536 [TBL] [Abstract][Full Text] [Related]
6. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503 [TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy. Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer. Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818 [TBL] [Abstract][Full Text] [Related]
10. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841 [TBL] [Abstract][Full Text] [Related]
11. Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy. Tabata M; Ikeda M; Urakami S; Takahashi S; Sakaguchi K; Kurosawa K; Okaneya T Jpn J Clin Oncol; 2015 Oct; 45(10):963-7. PubMed ID: 26130451 [TBL] [Abstract][Full Text] [Related]